Overview

Food Effects of GST-HG171 Tablets Combined With Ritonavir in Healthy Chinese Participants

Status:
Active, not recruiting
Trial end date:
2023-12-27
Target enrollment:
Participant gender:
Summary
A single-center, randomized, open, single-dose, two-cycle, two-sequence, cross-over study was conducted to evaluate the effect of food on the pharmacokinetic characteristics of GST-HG171 in combination with Ritonavir.
Phase:
Phase 1
Details
Lead Sponsor:
Fujian Akeylink Biotechnology Co., Ltd.
Treatments:
Ritonavir